When beginning treatment with Tirzepatide, a GLP-1 receptor agonist , close monitoring is essential to assess weight loss effectiveness and to make necessary adjustments to the dosage and patient lifestyle
There is no specific Zepbound or Mounjaro diet, but in clinical trials, people on tirzepatide lost weight by eating balanced meals and maintaining a 500-calorie deficit a day
This interval aligns with recommendations from the Bone Health and Osteoporosis Foundation (BHOF) and allows sufficient time to detect clinically meaningful changes in bone density while enabling timely intervention if significant loss is identified
Weight fluctuations of 2-3 pounds are normal due to fluid shifts, but sustained weight gain of more than 5 pounds over several weeks suggests an underlying issue
Stimulant-Free Energy & Keto Support
Most commercial insurers don't cover Wegovy for weight loss, though some may approve it if your doctor demonstrates medical necessity and you meet stringent criteria